These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 7201804

  • 1. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P, Ferry D, Lübbecke F, Glossmann H.
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [Abstract] [Full Text] [Related]

  • 2. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
    Bellemann P, Ferry D, Lübbecke F, Glossman H.
    Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
    [Abstract] [Full Text] [Related]

  • 3. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT, Gengo P, Klockowski R, Luchowski E, Siegel H, Janis RA, Triggle AM, Triggle DJ.
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [Abstract] [Full Text] [Related]

  • 4. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ, Murphy KM, Snyder SH.
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [Abstract] [Full Text] [Related]

  • 5. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR, Goll A, Glossmann H.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [Abstract] [Full Text] [Related]

  • 6. Molecular approach to the calcium channel.
    Glossmann H, Ferry DR, Goll A, Linn T.
    Adv Myocardiol; 1985 Jul; 5():41-76. PubMed ID: 2578683
    [Abstract] [Full Text] [Related]

  • 7. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT, Marcus KA, Daly JW, Skolnick P.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [Abstract] [Full Text] [Related]

  • 8. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT, Tremble P.
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
    Ishii A.
    Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
    [Abstract] [Full Text] [Related]

  • 10. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P.
    J Recept Res; 1984 Dec; 4(1-6):571-85. PubMed ID: 6084713
    [Abstract] [Full Text] [Related]

  • 11. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL, Yatani A, Brush K, Schwartz A, Brown AM.
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA, Sarmiento JG, Maurer SC, Bolger GT, Triggle DJ.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
    [Abstract] [Full Text] [Related]

  • 13. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A, Ukai Y, Matsuzaki T, Taniguchi N, Hayashi S, Kano S, Kimura Y, Kimura K, Enomoto H.
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [Abstract] [Full Text] [Related]

  • 14. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites.
    Ishii A, Nishida K, Oka T, Nakamizo N.
    Arzneimittelforschung; 1988 Nov; 38(11A):1681-3. PubMed ID: 3219140
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO, Carpenter CL, Greenberg DA.
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [Abstract] [Full Text] [Related]

  • 17. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA, Maurer SC, Sarmiento JG, Bolger GT, Triggle DJ.
    Eur J Pharmacol; 1982 Aug 27; 82(3-4):191-4. PubMed ID: 7128686
    [Abstract] [Full Text] [Related]

  • 18. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
    Bolger GT, Skolnick P.
    Br J Pharmacol; 1986 Aug 27; 88(4):857-66. PubMed ID: 3017494
    [Abstract] [Full Text] [Related]

  • 19. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG, Yamamura HI, Schoemaker H, Roeske WR.
    J Pharmacol Exp Ther; 1984 May 27; 229(2):333-9. PubMed ID: 6716261
    [Abstract] [Full Text] [Related]

  • 20. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
    Lee HR, Jaros JA, Roeske WR, Wiech NL, Ursillo R, Yamamura HI.
    J Pharmacol Exp Ther; 1985 Jun 27; 233(3):611-6. PubMed ID: 3159884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.